Ann: Mayne Pharma to restate US dermatology net revenue for FY22, page-6

I note they have also moved the reporting date back a few days from Feb 24 to Feb 28. Their update on Jan 12 showed that the results were scheduled for Feb 24. I wonder if today's announcement will have any bearing on the return of capital? I had given up on it, but anything is possible with this mob. They seem to move numbers and dates around as it suits them.

The optimist in me wants to believe they are trying to clear the decks and revitalise the company with sustainable profits, the pessimist in me is telling me to run for the hills.